{{Rsnum
|rsid=6504618
|Gene=SPOP
|Chromosome=17
|position=49608827
|Orientation=plus
|GMAF=0.4826
|Gene_s=SPOP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 28.3 | 51.3 | 20.4
| HCB | 28.5 | 48.9 | 22.6
| JPT | 39.8 | 46.9 | 13.3
| YRI | 10.9 | 52.4 | 36.7
| ASW | 12.3 | 49.1 | 38.6
| CHB | 28.5 | 48.9 | 22.6
| CHD | 26.6 | 54.1 | 19.3
| GIH | 21.8 | 50.5 | 27.7
| LWK | 13.6 | 38.2 | 48.2
| MEX | 19.0 | 51.7 | 29.3
| MKK | 14.7 | 51.3 | 34.0
| TSI | 34.3 | 53.9 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22688887
|Title=Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}